JPRN-UMIN000041007
Not yet recruiting
未知
Corticosteroids for patients with acute respiratory distress syndrome; systematic review and meta-analysis. - Corticosteroids for patients with acute respiratory distress syndrome; systematic review and meta-analysis.
JA General Hospital.0 sites0 target enrollmentJuly 5, 2020
ConditionsAcute respiratory distress syndrome
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute respiratory distress syndrome
- Sponsor
- JA General Hospital.
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\- Cardiac edema \- Hypercapnia without hypoxia \- Contraindication of steroids \- Diseases which steroids is effective \- History of steroids use by some months before inclusion \- No ventilation \- Acute lung injury associated with immaturity and congenital malformations
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Preterm Paediatric Inhaled Corticosteroid Intervention (PICSI)ACTRN12618000781246Telethon Kids Institute214
Recruiting
Not Applicable
Corticosteroids in Severe COVID-19(ASAP-C Study)Severe COVID-19NCT04648410Brno University Hospital2,000
Completed
Not Applicable
Randomised controlled trial of nebulised budesonide versus oral prednisolone in acute severe asthma in childreHealth Condition 1: null- Bronchial asthmaHealth Condition 2: J455- Severe persistent asthmaCTRI/2013/11/004162Department of Pediatrics Institute of Child Heath Egmore Chennai80
Active, not recruiting
Phase 1
treatment with inhaled corticoids in patients with covid-19 and pneumoniaCOVID19MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001616-18-ESFundació Clinic per a la Recerca Biomèdica300
Active, not recruiting
Phase 1
Treating COVID-19 infections with inhaled corticosteroidsCOVID 19Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-001889-10-GBniversity of Oxford, Clinical Trials and Research Governance478